114 related articles for article (PubMed ID: 22852560)
41. Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual.
Pibernik-Okanović M; Ajduković D; Lovrenčić MV; Hermanns N
Trials; 2011 Jan; 12():17. PubMed ID: 21251307
[TBL] [Abstract][Full Text] [Related]
42. Psychological responses to genetic testing for weight gain: a vignette study.
Meisel SF; Walker C; Wardle J
Obesity (Silver Spring); 2012 Mar; 20(3):540-6. PubMed ID: 22030987
[TBL] [Abstract][Full Text] [Related]
43. Computer-supported indirect-form lifestyle-modification support program using Lifestyle Intervention Support Software for Diabetes Prevention (LISS-DP) for people with a family history of type 2 diabetes in a medical checkup setting: a randomized controlled trial.
Tokunaga-Nakawatase Y; Nishigaki M; Taru C; Miyawaki I; Nishida J; Kosaka S; Sanada H; Kazuma K
Prim Care Diabetes; 2014 Oct; 8(3):207-14. PubMed ID: 24529485
[TBL] [Abstract][Full Text] [Related]
44. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
45. The Tyrolean early vascular ageing-study (EVA-Tyrol): study protocol for a non-randomized controlled trial : Effect of a cardiovascular health promotion program in youth, a prospective cohort study.
Bernar B; Gande N; Stock KA; Staudt A; Pechlaner R; Geiger R; Griesmacher A; Kiechl S; Knoflach M; Kiechl-Kohlendorfer U;
BMC Cardiovasc Disord; 2020 Feb; 20(1):59. PubMed ID: 32024473
[TBL] [Abstract][Full Text] [Related]
46. Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing.
Vassy JL; O'Brien KE; Waxler JL; Park ER; Delahanty LM; Florez JC; Meigs JB; Grant RW
Med Decis Making; 2012; 32(4):606-15. PubMed ID: 22247420
[TBL] [Abstract][Full Text] [Related]
47. Study protocol of a pragmatic randomized controlled trial incorporated into the Group Lifestyle Balance™ program: the nutrigenomics, overweight/obesity and weight management trial (the NOW trial).
Horne J; Gilliland J; O'Connor C; Seabrook J; Hannaberg P; Madill J
BMC Public Health; 2019 Mar; 19(1):310. PubMed ID: 30876469
[TBL] [Abstract][Full Text] [Related]
48. Type-2 diabetes primary prevention program implemented in routine primary care: a process evaluation study.
Sánchez A; Silvestre C; Campo N; Grandes G;
Trials; 2016 May; 17(1):254. PubMed ID: 27206733
[TBL] [Abstract][Full Text] [Related]
49. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.
Cameron LD; Sherman KA; Marteau TM; Brown PM
Health Psychol; 2009 May; 28(3):307-16. PubMed ID: 19450036
[TBL] [Abstract][Full Text] [Related]
50. Informing patients of familial diabetes mellitus risk: How do they respond? A cross-sectional survey.
Qureshi N; Kai J
BMC Health Serv Res; 2008 Feb; 8():37. PubMed ID: 18257922
[TBL] [Abstract][Full Text] [Related]
51. Evaluating genetic counseling for individuals with schizophrenia in the molecular age.
Costain G; Esplen MJ; Toner B; Scherer SW; Meschino WS; Hodgkinson KA; Bassett AS
Schizophr Bull; 2014 Jan; 40(1):78-87. PubMed ID: 23236078
[TBL] [Abstract][Full Text] [Related]
52. Impact of delivery models on understanding genomic risk for type 2 diabetes.
Haga SB; Barry WT; Mills R; Svetkey L; Suchindran S; Willard HF; Ginsburg GS
Public Health Genomics; 2014; 17(2):95-104. PubMed ID: 24577154
[TBL] [Abstract][Full Text] [Related]
53. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey.
Grant RW; Hivert M; Pandiscio JC; Florez JC; Nathan DM; Meigs JB
Diabetologia; 2009 Nov; 52(11):2299-2305. PubMed ID: 19727660
[TBL] [Abstract][Full Text] [Related]
54. Genetic screening for the risk of type 2 diabetes: worthless or valuable?
Lyssenko V; Laakso M
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S120-6. PubMed ID: 23882036
[No Abstract] [Full Text] [Related]
55. Public trust in genomic risk assessment for type 2 diabetes mellitus.
Mills R; Barry W; Haga SB
J Genet Couns; 2014 Jun; 23(3):401-8. PubMed ID: 24292896
[TBL] [Abstract][Full Text] [Related]
56. Patients' understanding of and responses to multiplex genetic susceptibility test results.
Kaphingst KA; McBride CM; Wade C; Alford SH; Reid R; Larson E; Baxevanis AD; Brody LC
Genet Med; 2012 Jul; 14(7):681-7. PubMed ID: 22481132
[TBL] [Abstract][Full Text] [Related]
57. Randomized controlled trial of the effectiveness of genetic counseling and a distance, computer-based, lifestyle intervention program for adult offspring of patients with type 2 diabetes: background, study protocol, and baseline patient characteristics.
Nishigaki M; Tokunaga-Nakawatase Y; Nishida J; Taru C; Miyawaki I; Sanada H; Kazuma K
J Nutr Metab; 2012; 2012():831735. PubMed ID: 22619705
[TBL] [Abstract][Full Text] [Related]
58. Risk communication in genetic counseling: Exploring uptake and perception of recurrence numbers, and their impact on patient outcomes.
Borle K; Morris E; Inglis A; Austin J
Clin Genet; 2018 Aug; 94(2):239-245. PubMed ID: 29766486
[TBL] [Abstract][Full Text] [Related]
59. Predisposed to risk but not change.
Collier R
CMAJ; 2012 May; 184(8):E407-8. PubMed ID: 22451691
[No Abstract] [Full Text] [Related]
60. Genetic Counseling For Predictive Retinal Imaging.
De Silva SR; Mahroo OA; Charbel Issa P
JAMA Ophthalmol; 2024 Jan; 142(1):5-6. PubMed ID: 37991754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
